| |
Learning Objectives
After completing this presentation, the viewer will be able to:
-
Identify the treatment goals for HIV patients with chronic hepatitis B infection.
- Differentiate the criteria for beginning either hepatitis B or HIV antiretroviral treatment in a patient co-infected with hepatitis B and HIV.
- Describe a treatment strategy that would reduce both hepatitis B and HIV viral replication and impact on health.
FACULTY
Kathleen Casey, MD, is Medical Director of the A-Team at Jersey Shore University Medical Center in Neptune, NJ, and Clinical Professor of Medicine at UMDNJ-Robert Wood Johnson Medical School.
Target Audience
This activity is designed for physicians, nurses, and other health care professionals in New Jersey who are involved in the care of adolescents and adults who may be infected with HIV/AIDS.
STATEMENT OF NEED
People with HIV/AIDS are living longer with more effective antiretroviral medications (ARVs), but have also developed co-morbidities and resistance to ARVs with continued use and interactions with treatments for co-morbidities. As new medications are approved and research results published, HIV management is in a continued state of flux and HIV care providers are often too burdened with patient case loads to be able to individually remain as up to date on the most current standards of care as they need to be in order to provide excellence in HIV care.
The goal of this web-based activity is to provide current HIV treatment information in an accessible format, to reach health care professionals who did not attend the 2007 NJDHSS-UMDNJ statewide HIV conference with three of the most critical topics addressed at that event. This activity is designed to update physicians, nurses, physician assistants, pharmacists and other HIV health care providers on the most recent developments in the care and management of HIV disease and co-morbidities; specific clinical concerns in the effective treatment of women with HIV/AIDS, and interactions between HIV medications, over-the-counter (OTC) medications, and recreational drugs.
METHOD OF INSTRUCTION
Participants should read the learning objectives and review the activity in its entirety. After reviewing the material, complete the self-assessment test consisting of a series of multiple-choice and True/ False questions.
Upon completing this activity as designed and achieving a passing score of 70% or more on the self-assessment test, participants will receive a credit letter and the test answer key four (4) weeks after receipt of the self-assessment test, registration, and evaluation materials. Estimated time to complete this activity as designed is 1.25 hours.
Accreditation
PHYSICIANS: UMDNJ–Center for Continuing and Outreach Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. UMDNJ–Center for Continuing and Outreach Education designates this educational activity for a maximum of 1.25 AMA PRA Category 1 credit(s)™. Each physician should claim only those credits that he/she actually spent in the activity.
NURSES: The University of Medicine and Dentistry of New Jersey-Continuing Education and Outreach Education is an approved provider of continuing nursing education by the New Jersey State Nurses Association, Provider Number P173-10/06-09. New Jersey State Nurses Association is accredited by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is awarded 1.25 contact hours.
UMDNJ-Center for Continuing and Outreach Education is an approved provider of continuing education by the California Board of Registered Nursing, Provider Number CEP 13780 for a maximum of 1.25 contact hours for this activity.
REVIEW
The activity was prepared in accordance with the ACCME Essentials. This activity was reviewed for relevance, accuracy of content, balance of presentation, and time required for participation by Patricia Kloser, MD, MPH. This activity was reviewed for relevance, accuracy of content, balance of presentation, and time required for participation by Bonnie Abedini, RN, MSN; Mary C. Krug RN, MSN, APN-C; and Debbie Y. Mohammed, MS, APRN-BC, ACRN.
Disclosure
In accordance with the disclosure policies of UMDNJ and to conform with ACCME and FDA guidelines, all program faculty are required to disclose to the activity participants: 1) the existence of any financial interest or other relationships with the manufacturers of any commercial products/devices, or providers of commercial services, that relate to the content of their presentation/material, or the commercial contributors of this activity, that could be perceived as a real or apparent conflict of interest; and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/ device not yet approved.
Disclosure Declaration
Kathleen Casey has the following financial relationships to disclose: Speakers Bureau: Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb; Gilead Sciences, GlaxoSmithKline, Pfizer, and Tibotec.
The following have no financial relationships to disclose: Patricia Kloser, MD, MPH (Field Tester and Activity Director); CE Reviewers: Bonnie Abedini, RN, MSN; Mary C.Krug RN, MSN, APN-C; and Debbie Y.Mohammed, MS, APRN-BC, ACRN.
OFF LABEL USAGE
This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.
Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of NJDHSS-Division of HIV/AIDS Services, UMDNJ, or any manufacturer of pharmaceuticals. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult the full prescribing information on any agent(s) presented in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication. This is particularly important when a drug is new or infrequently prescribed.
Copyright © 2007 UMDNJ-Center for Continuing & Outreach Education. All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from UMDNJ-Center for Continuing & Outreach Education.
Please direct CME related questions to UMDNJ at 973-972-4267 or email ccoereg@umdnj.edu. To review UMDNJ's privacy policy, click here.
GRANTOR ACKNOWLEDGEMENT
Sponsored by the University of Medicine & Dentistry of New Jersey (UMDNJ), UMDNJ-Center for Continuing & Outreach Education. This activity is supported by an educational grant from NJDHSS Division of HIV/AIDS Services through a MOA titled “Education and Training for Physicians and other Healthcare Professionals in the Diagnosis and Treatment of HIV/AIDS.”
|
|
